TrialThe oncologist2020

Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab-Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non-Small Cell Lung Cancer.

Yuko Tsuchiya-Kawano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.